Stockholm Stock Exchange | Mid Cap
Bonesupport
+44.36%
Latest
+83.23%
3 months
SEBDNB CarnegieNordeaCarnegieSEB EquitiesABG Sundal Collier

Price Targets For Bonesupport

AnalystPrice TargetDateUpside
SEB260 SEKOct -25
+44.36%
DNB Carnegie400 SEKOct -25
Nordea370 SEKSep -25
Carnegie380 SEKOct -24
SEB Equities332 SEKOct -24
ABG Sundal Collier310 SEKApr -24

About The Company

Bonesupport Holding AB is a Swedish pharmaceutical company that develops and markets the synthetic injectable bone graft substitute Cerament, which is used in the treatment of skeletal injuries. Bonesupport was founded in the early 2000s as a research company in Lund by orthopedist Lars Lidgren.
Wikipedia